Histogen Inc (HSTO)
0.351
0.00 (0.00%)
USD |
OTCM |
Apr 26, 11:25
Histogen Shareholders Equity (Quarterly): 5.436M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.436M |
| June 30, 2023 | 9.294M |
| March 31, 2023 | 11.35M |
| December 31, 2022 | 14.40M |
| September 30, 2022 | 17.28M |
| June 30, 2022 | 16.33M |
| March 31, 2022 | 20.68M |
| December 31, 2021 | 21.19M |
| Date | Value |
|---|---|
| September 30, 2021 | 21.26M |
| June 30, 2021 | 24.93M |
| March 31, 2021 | 22.59M |
| December 31, 2020 | 7.86M |
| September 30, 2020 | 7.445M |
| June 30, 2020 | 9.232M |
| December 31, 2019 | -37.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-37.07M
Minimum
Dec 2019
24.93M
Maximum
Jun 2021
11.48M
Average
14.40M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.817M |
| Total Liabilities (Quarterly) | 1.413M |
| Current Ratio | 4.047 |